MILFORD, Mass., June 23 (Bernama-BUSINESS WIRE) -- Waters Corporation (NYSE:WAT) today announced a joint effort with the Bioprocessing Technology Institute
(BTI), a research institute within Singapore's Agency for Science,
Technology and Research (A*STAR), to develop new methods of finding
cancer markers and elucidating glycosylation pathways that could pave
the way for new therapeutic strategies.
As part of the research
collaboration, Waters and BTI will develop a glycosphingolipid (GSL)
head group database containing glucose unit (GU) retention times1
and collision cross-section (CCS) values in an effort to compile an
experimental library for disease-related GSL glycans together with a
glycan/MS spectral library.
http://mrem.bernama.com/viewsm.php?idm=27026
No comments:
Post a Comment